Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany

References

• Advisory Committee on Immunization Practice, Centers for Disease Control and Prevention. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control 2011; 60:1-45
   Google Scholar
• Publication WHO. World Health Organization: Hepatitis B Vaccines: WHO position paper. Vaccine 2010; 28:589-90; http://dx.doi.org/10.1016/j.vaccine.2009.10.110
   PubMed Web of Science ®Google Scholar
• Ständige Impfkommission. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: August 2014. Epidemiologisches Bulletin 34/2014. 2014
   Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53:68-75; PMID:21653306; http://dx.doi.org/10.1093/cid/cir270
   PubMed Web of Science ®Google Scholar
• Fitzsimons D, Francois G, Hall A, McMahon B, Meheus A, Zanetti A, Duval B, Jilg W, Bocher WO, Lu SN, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23:4158-66; PMID:15964484; http://dx.doi.org/10.1016/j.vaccine.2005.03.017
   PubMed Web of Science ®Google Scholar
• Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355:561-5; PMID:10683019; http://dx.doi.org/10.1016/S0140-6736(99)07239-6
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practice, Centers for Disease Control and Prevention: Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports :Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control, 2011:1-45
   Web of Science ®Google Scholar
• Impfkommission S. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2012. Epidemiologisches Bulletin 2012; 30:290-1
   Google Scholar
• Bundesamt für Gesundheit: Schweizerischer Impfplan. 2012. Available at: http://www.bag.admin.ch/ekif/04423/04428/
   Google Scholar
• Health Do. Immunisation against infectious disease. In: Department of Health L, UK, ed., 2006
   Google Scholar
• Jilg W, Schmidt M, Deinhardt F. Four-year experience with a recombinant hepatitis B vaccine. Infection 1989; 17:70-6; PMID:2714860; http://dx.doi.org/10.1007/BF01646879
   PubMed Web of Science ®Google Scholar
• Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population–results of a 10-year study. J Infect Dis 1997; 175:674-7; PMID:9041341; http://dx.doi.org/10.1093/infdis/175.3.674
   PubMed Web of Science ®Google Scholar
• Behre U, Bleckmann G, Crasta PD, Leyssen M, Messier M, Jacquet JM, Hardt K. Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8:813-8; PMID:22508412; http://dx.doi.org/10.4161/hv.19898
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Poethko-Muller C, Hellenbrand W, Jilg W, Thierfelder W, Meyer C, an der Heiden M, Schlaud M, Radun D. Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003–2006. Epidemiol Infect 2010; 138:1621-9; PMID:20233496; http://dx.doi.org/10.1017/S0950268810000543
   PubMed Web of Science ®Google Scholar
• Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J, Soemantri P, Grunert D, Laakmann KH, Gunasekaran R, et al. Immune memory to hepatitis B virus in 4–9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine. Hum Vaccin 2009; 5:592-8; PMID:19535920; http://dx.doi.org/10.4161/hv.9051
   PubMed Web of Science ®Google Scholar
• Van Der Meeren O, Bleckmann G, Crasta PD. Immune memory to hepatitis B persists in children aged 7–8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix hexa) vaccine. Hum Vaccin Immunother 2014; 10:1682-7; PMID:24637296; http://dx.doi.org/10.4161/hv.28480
   PubMed Web of Science ®Google Scholar
• Jilg W, Schmidt M, Deinhardt F, Zachoval R. Hepatitis B vaccination: how long does protection last? Lancet 1984; 2:458; PMID:6147519; http://dx.doi.org/10.1016/S0140-6736(84)92926-X
   PubMed Web of Science ®Google Scholar
• Jilg W, Schmidt M, Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988; 6:201-7; PMID:2970501; http://dx.doi.org/10.1016/S0168-8278(88)80032-1
   PubMed Web of Science ®Google Scholar
• Spada E, Romano L, Tosti ME, Zuccaro O, Paladini S, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, et al. Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect 2014; 20:O680-6; PMID:24528380; http://dx.doi.org/10.1111/1469-0691.12591
   PubMedGoogle Scholar
• Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR. Duration of protection after infant hepatitis B vaccination series. Pediatrics 2014; 133:e1500-7; PMID:24843060; http://dx.doi.org/10.1542/peds.2013-2940
   PubMed Web of Science ®Google Scholar
• Schonberger K, Riedel C, Ruckinger S, Mansmann U, Jilg W, Kries RV. Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis. Pediatr Infect Dis J 2013; 32:307-13; PMID:23249904; http://dx.doi.org/10.1097/INF.0b013e31827bd1b0
   PubMed Web of Science ®Google Scholar
• Kesler K, Nasenbeny J, Wainwright R, McMahon B, Bulkow L. Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age. Pediatr Infect Disease J 1998; 17:116-9; PMID:9493806; http://dx.doi.org/10.1097/00006454-199802000-00007
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol 2013; 42:1012-4; PMID:24062287; http://dx.doi.org/10.1093/ije/dys223
   PubMed Web of Science ®Google Scholar
• Neuhauser H, Poethko-Muller C, Ki GGSSG. [Chronic and vaccine-preventable diseases in children and adolescents in Germany: results of the KiGGS study: first follow up (KiGGS wave 1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2014; 57:779-88; PMID:24950827; http://dx.doi.org/10.1007/s00103-014-1976-6
   PubMed Web of Science ®Google Scholar